Advertisement

Index by author

September 01, 2014; Volume 350,Issue 3

  1. Fagan, Susan C.

    1. Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis
      Ahmed Alhusban, Ahmad Al-Azayzih, Anna Goc, Fei Gao, Susan C. Fagan and Payaningal R. Somanath
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 635-645; DOI: https://doi.org/10.1124/jpet.114.216382

  2. Ferru-clement, Romain

    1. Searching for Combinations of Small-Molecule Correctors to Restore F508del–Cystic Fibrosis Transmembrane Conductance Regulator Function and Processing
      Clément Boinot, Mathilde Jollivet Souchet, Romain Ferru-Clément and Frédéric Becq
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 624-634; DOI: https://doi.org/10.1124/jpet.114.214890

  3. Fischer, W.

    1. Tanshinone II A Sulfonate, but Not Tanshinone II A, Acts as Potent Negative Allosteric Modulator of the Human Purinergic Receptor P2X7
      M. Kaiser, H. Sobottka, W. Fischer, M. Schaefer and W. Nörenberg
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 531-542; DOI: https://doi.org/10.1124/jpet.114.214569

  4. Fonsi, Massimiliano

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  5. Freels, Parker D.

    1. Targeted Injection of a Biocomposite Material Alters Macrophage and Fibroblast Phenotype and Function following Myocardial Infarction: Relation to Left Ventricular Remodeling
      Jeremy R. McGarvey, Sara Pettaway, James A. Shuman, Craig P. Novack, Kia N. Zellars, Parker D. Freels, Randall L. Echols, Jason A. Burdick, Joseph H. Gorman, Robert C. Gorman and Francis G. Spinale
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 701-709; DOI: https://doi.org/10.1124/jpet.114.215798

  6. Fujimura, Morihiro

    1. Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
      Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

  7. Futamura, Takashi

    1. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793
Back to top

In this issue

Advertisement